Driving research, providing support and improving outcomes for patients and their families affected by rare conditions



We are committed to supporting the highest standard of research in pursuit of our mission.

Since 2021 the Myrovlytis Trust has committed to spend over £1million in funding vital research for the rare conditions of Birt-Hogg Dubé Syndrome and osteosarcoma.

A review was carried out in Spring 2024 and the decision has been made to not run a funding round in 2024.

Some of our current funded projects are due to end in 2024. And some will run through to 2027. We are taking time to work with the research teams to review the work that has been carried out to date on each funded project. This will allow us to better understand and identify which areas of research we would like to support and fund in the future.

We will carry out a further review of a 2025 funding round in our AGM in November 2024 and will announce the outcome by early Spring 2025.

Feel free to drop us a line with any questions about our funding by emailing us at contact@myrovlytistrust.org We love to hear from the community and welcome all feedback!

Current funding opportunities can be found by visiting https://www.grants.gov/ or https://www.grantfinder.co.uk/ 




Osteosarcoma Institute
Bardo Foundation
Rare Revolution Magazine
Gene People logo
Gene People logo
Sarcoma Patient advocacy Global Network

Connect with us…

Back to top